HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LL-37 protects rats against lethal sepsis caused by gram-negative bacteria.

Abstract
We investigated the efficacy of LL-37, the C-terminal part of the only cathelicidin in humans identified to date (termed human cationic antimicrobial protein), in three experimental rat models of gram-negative sepsis. Adult male Wistar rats (i) were given an intraperitoneal injection of 1 mg Escherichia coli 0111:B4 LPS, (ii) were given 2 x 10(10) CFU of Escherichia coli ATCC 25922, or (iii) had intra-abdominal sepsis induced via cecal ligation and puncture. For each model, all animals were randomized to receive intravenously isotonic sodium chloride solution, 1-mg/kg LL-37, 1-mg/kg polymyxin B, 20-mg/kg imipenem, or 60-mg/kg piperacillin. Lethality; growth of bacteria in blood, peritoneum, spleen, liver, and mesenteric lymph nodes; and endotoxin and tumor necrosis factor alpha (TNF-alpha) concentrations in plasma were evaluated. All compounds reduced lethality compared to levels in controls. Endotoxin and TNF-alpha plasma levels were significantly higher in conventional antibiotic-treated rats than in LL-37- and polymyxin B-treated animals. All drugs tested significantly reduced bacterial growth compared to saline treatment. No statistically significant differences between LL-37 and polymyxin B were noted for antimicrobial and antiendotoxin activities. LL-37 and imipenem proved to be the most effective treatments in reducing all variables measured. Due to its multifunctional properties, LL-37 may become an important future consideration for the treatment of sepsis.
AuthorsOscar Cirioni, Andrea Giacometti, Roberto Ghiselli, Cristina Bergnach, Fiorenza Orlando, Carmela Silvestri, Federico Mocchegiani, Alberto Licci, Barbara Skerlavaj, Marco Rocchi, Vittorio Saba, Margherita Zanetti, Giorgio Scalise
JournalAntimicrobial agents and chemotherapy (Antimicrob Agents Chemother) Vol. 50 Issue 5 Pg. 1672-9 (May 2006) ISSN: 0066-4804 [Print] United States
PMID16641434 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Antimicrobial Cationic Peptides
  • Endotoxins
  • Nitrites
  • Tumor Necrosis Factor-alpha
  • Imipenem
  • Polymyxin B
  • Piperacillin
  • Cathelicidins
Topics
  • Animals
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Antimicrobial Cationic Peptides (pharmacology, therapeutic use)
  • Cecum (microbiology)
  • Disease Models, Animal
  • Endotoxins (blood)
  • Escherichia coli (classification, drug effects)
  • Escherichia coli Infections (drug therapy, microbiology)
  • Gram-Negative Bacteria (classification, drug effects)
  • Imipenem (administration & dosage)
  • Injections, Intraperitoneal
  • Male
  • Nitrites (metabolism)
  • Piperacillin (administration & dosage)
  • Polymyxin B (administration & dosage)
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Serotyping
  • Shock, Septic (drug therapy, microbiology)
  • Tumor Necrosis Factor-alpha (analysis)
  • Cathelicidins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: